Elliot Grossbard

Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials

James B. Bussel, Donald M. Arnold, Elliot Grossbard et al. · American Journal of Hematology · 2018 · 329 citations · Full text

Clinical Immunology, Immunodeficiencies, Immunology +19

Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk

Anna J. Podolanczuk, Alan H. Lazarus, Andrew R. Crow et al. · Blood · 2008 · 269 citations · Full text

Hyperfractionated total body irradiation for bone marrow transplantation: I. early results in leukemia patients

Brenda Shank, Seymour Hopfan, Jae Ho Kim et al. · International Journal of Radiation Oncology*Biology*Physics · 1981 · 127 citations

Transplantation, Marrow Transplantation, Radiation Therapy +9

Evidence for a Proliferative Advantage of Human Leukemia Colony-Forming Cells In Vitro 23

Hal E. Broxmeyer, Elliot Grossbard, N Jacobsen et al. · JNCI Journal of the National Cancer Institute · 1978 · 61 citations

Immune Regulation, Immunology, Cell Proliferation +22

Mast cell inhibitor R112 is well tolerated and affects prostaglandin D₂ but not other mediators, symptoms, or nasal volumes in a nasal challenge model of allergic rhinitis

Brenda J. Guyer, S. Reed Shimamoto, A. Bradhurst et al. · Allergy and Asthma Proceedings · 2006 · 29 citations

Asthma, Crossover Trial, Allergy Medicine +17